Surgical Science Sweden AB (publ) (STO:SUS)
53.35
-0.80 (-1.48%)
Oct 15, 2026, 3:29 PM CET
STO:SUS Market Cap
STO:SUS has a market cap or net worth of 2.72 billion as of October 15, 2026. It is the 18,823rd most valuable company in the world and the 231st biggest in Sweden. Its market cap has decreased by 36.83% in one year.
Market Cap
2.72B
Enterprise Value
2.07B
Revenue
1.02B
Global Rank
Country Rank
#231 Sweden
PE Ratio
29.75
ChartMarket Cap Chart
Since June 19, 2017, STO:SUS's market cap has increased from 279.67M to 2.72B, an increase of 873.37%. That is a compound annual growth rate of 27.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 2.72B | 64.15% |
| Dec 30, 2025 | 1.66B | -79.15% |
| Dec 30, 2024 | 7.95B | -14.58% |
| Dec 29, 2023 | 9.31B | 11.30% |
| Dec 30, 2022 | 8.37B | -41.49% |
| Dec 30, 2021 | 14.30B | 343.39% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 152.36B |
| Getinge AB | 69.67B |
| Sectra AB | 59.38B |
| Medicover AB | 39.82B |
| CellaVision AB | 3.87B |
| Hansa Biopharma AB | 3.65B |
| Humana AB | 3.36B |
| Vicore Pharma Holding AB | 2.51B |